Read news release HERE
The post Satellos, a CureDuchenne funded company, just announced the first participant was dosed in their Phase 2 pediatric study of SAT-3247 for Duchenne muscular dystrophy. appeared first on CureDuchenne.
Categories
Recent Posts
- MDA Ambassador Guest Blog: Grateful for the One by My Side on Valentine’s Day (and Every Day)
- Trial testing gene-editing therapy PBGENE-DMD gets FDA green light
- Satellos, a CureDuchenne funded company, just announced the first participant was dosed in their Phase 2 pediatric study of SAT-3247 for Duchenne muscular dystrophy.
- PTC Therapeutics Provides Regulatory Update on Translarna™ (atalauren)
- A winter blizzard had me cooped up at home for days
Archive
- February 2026
- January 2026
- December 2025
- November 2025
- October 2025
- September 2025
- August 2025
- July 2025
- June 2025
- May 2025
- April 2025
- March 2025
- February 2025
- January 2025
- December 2024
- November 2024
- October 2024
- September 2024
- August 2024
- July 2024
- June 2024
- May 2024
- April 2024
- March 2024
- February 2024
- January 2024